Synergistic combination of xolair/omalizumab/e25 with...

Details Synergistic combination of xolair/omalizumab/e25 with... Synergistic combination of xolair/omalizumab/e25 with...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 37/08 (2006.01)

Patent

CA 2595976

The present invention provides a pharmaceutical composition comprising an Anti- lgE Antibody and at least one further immunosuppressive agent, in which the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use.

L'invention concerne une composition pharmaceutique comprenant un anticorps anti-IgE, et au moins un agent immunosuppresseur additionnel, dans laquelle les ingrédients actifs sont présentés dans chaque cas sous forme libre ou sous forme d'un sel pharmaceutiquement acceptable, et éventuellement au moins un excipient pharmaceutiquement acceptable, et sont destinés à être administré simultanément, séparément, ou successivement.

Affiliated with

Also associated with

Rating

Synergistic combination of xolair/omalizumab/e25 with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic combination of xolair/omalizumab/e25 with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic combination of xolair/omalizumab/e25 with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1818708